| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Sr VP, Clinical Research &Dev
1 company
Bryce Richard Paul is a See Remarks at PUMA BIOTECHNOLOGY, INC.. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $961K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2020 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 89 | $10.66 | $948.74 | -0.1% | |
| May 4, 2020 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 89 | $9.62 | $856.19 | -0.1% | |
| Apr 2, 2020 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 91 | $7.37 | $670.68 | -0.1% | |
| Mar 2, 2020 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 96 | $10.02 | $962.15 | -0.1% | |
| Feb 3, 2020 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 105 | $8.02 | $841.58 | -0.3% | |
| Jan 2, 2020 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 1,516 | $8.40 | $12,734.32 | -2.1% | |
| Dec 2, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 83 | $10.34 | $858.23 | -0.2% | |
| Nov 4, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 88 | $7.38 | $649.45 | -0.2% | |
| Oct 2, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 91 | $10.05 | $914.55 | -0.2% | |
| Sep 4, 2019 | PBYI Puma Biotechnology, Inc. | See Remarks | Sell | 95 | $10.11 | $960.45 | -0.3% |